MRNA Trade on May 7, 2020 10:07 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine

Technical Analysis

-SPY pattern: Consolidation
-Intraday pattern: Bowl
-Levels: 51.5, 53.5, 55.5 - 56, 59

Strategy / Confluence / Sizing Guide / Risk

Strategy: FT-15 Long of 51.75 level
Confluence: Gap fill
Sizing (lots): 3
Risk (stop / Rs): hold below 51.5

Review / Lessons Learned

Honestly was rattled by my PM loss in MRNA and simply didn't trust the ticker, it traded very tightly all day and pretty much did nothing, glad I didn't take this one with full size although the right thing to do would have been to take with proper size, but simply couldn't bring myself to do it. (redeemed myself later in the day with SPCE)

Lessons Learned: Get to full size!